Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

OTLK stock hub

Outlook Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

OTLKis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

23.2M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

OTLK

In the news

Latest news · OTLK

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROEn/a

P25 -105.6P50 -46.5P75 -3.1

ROICn/a

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All OTLK market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

189

Groups with data

Currency

USD

Showing 189 of 189 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001649989
Company name	Outlook Therapeutics, Inc.
Country	United States
Country code	US
Cusip	69012T206
Employees	17
Employees Change	-6%
Employees Change Percent	-26.09
Enterprise value	$51.4M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2016-05-13
Isin	US69012T3059
Last refreshed	2026-05-10
Market cap	$23.2M
Market cap category	Nano-Cap
Price	$0.22
Price currency	USD
Rev Per Employee	12,100.12x
Sector	Healthcare
Sic	2836
Symbol	OTLK
Website	https://outlooktherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-444.3%
EV Sales Forward	1.84x
EV/Sales	249.71x
FCF yield	-241.03%
P/S ratio	112.55x
PS Forward	0.83x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-22.3M
Net Income	$-102.9M
Net Income Growth Years	1%
Pretax Margin	-50,759.08%
Profit Per Employee	$-6.1M
ROA	-209
Roa5y	-147.6
ROCE	191.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-84.32%
Cagr3y	-78.72%
Cagr5y	-65.21%
EPS Growth Years	10
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.01
Assets	$18.2M
Cash	$8.7M
Current Assets	$17.2M
Current Liabilities	$49.1M
Debt	$36.9M
Equity	$-38.5M
Interest Coverage	-208.2
Liabilities	$56.8M
Long Term Assets	$1.1M
Long Term Liabilities	$7.7M
Net Cash	$-28.2M
Net Cash By Market Cap	$-122
Tangible Book Value	$-38.5M
Tangible Book Value Per Share	$-0.6
WACC	2.72

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.35
Inventory Turnover	6.86
Net Working Capital	$-3.8M
Quick ratio	0.18
Working Capital	$-31.9M
Working Capital Turnover	$-0.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-105.06%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-84.3%
200-day SMA	1.07
3Y total return	-99.04%
50-day SMA	0.3
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.49%
All Time High	878.4
All Time High Change	-99.97%
All Time High Date	2016-09-01
All Time Low	0.16
All Time Low Change	37.37%
All Time Low Date	2026-03-24
ATR	0.03
Beta	0.33
Beta1y	2.44
Beta2y	1.2
Ch YTD	-85.99
High	0.23
High52	3.39
High52 Date	2025-08-26
High52ch	-93.47%
Low	0.22
Low52	0.16
Low52 Date	2026-03-24
Low52ch	37.37%
Ma50ch	-26.33%
Premarket Change Percent	2.46
Premarket Price	$0.22
Premarket Volume	391,331
Price vs 200-day SMA	-79.28%
RSI	39.47
RSI Monthly	34.33
RSI Weekly	32.27
Sharpe ratio	-0.53x
Sortino ratio	-0.62
Tr YTD	-85.99
Tr1m	3.9%
Tr1w	-15.6%
Tr3m	-48.46%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Count Top	2
Analyst Price Target Top	$0.75
Analyst Ratings	Buy
Analyst Ratings Top	Hold
Earnings EPS Estimate	$-0.12
Earnings Revenue Estimate	4,400,000x
Operating Income	$-58.9M
Operating margin	-28,652.5
Price target	$2.5
Price Target Change	$1,030
Price Target Change Top	$239

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	89,280,210%
Float Percent	85.34%
Net Borrowing	-3,042,586
Shares Insiders	0.07%
Shares Institutions	13.73%
Shares Out	104,614,219
Shares Qo Q	27.57%
Shares Yo Y	105.06%
Short Float	5.25%
Short Ratio	0.99
Short Shares	4.48

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-61.9M
Average Volume	4,835,335.45x
Bv Per Share	-0.6
Ch1m	3.9
Ch1w	-15.6
Ch1y	-84.3
Ch3m	-48.46
Ch3y	-99.04
Ch5y	-99.49
Ch6m	-81.4
Change	2.6%
Change From Open	0.59
Close	0.22
Days Gap	1.99
Depreciation Amortization	118,325
Dollar Volume	715,624.9
Earnings Date	2026-05-14
Earnings Time	amc
EBIT	$-58.9M
EBITDA	$-58.8M
EPS	$-2.35
F Score	2
FCF	$-55.8M
FCF EV Yield	-108.63x
FCF Per Share	$-0.53
Financing CF	58,776,061
Fiscal Year End	September
Founded	2,010
Income Tax	$-1.6M
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-02-17
Last Report Date	2025-12-31
Last Split Date	2024-03-14
Last Split Type	Reverse
Last10k Filing Date	2025-12-19
Ma150	0.89
Ma150ch	-75.13%
Ma20	0.27
Ma20ch	-18.49%
Net CF	2,974,848
Next Earnings Date	2026-05-22
Open	0.22
Optionable	Yes
Position In Range	17.33
Post Close	0.22
Postmarket Change Percent	2.08
Postmarket Price	$0.23
Ppne	212,413
Pre Close	0.22
Price Date	2026-05-08
Relative Volume	0.67x
Revenue	205,702x
SBC By Revenue	2,968.67x
Share Based Comp	6,106,617
Tax By Revenue	-754.41x
Tr6m	-81.4%
Us State	New Jersey
Volume	3,233,732
Z Score	-60.32

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does OTLK pay a dividend?

Capital-return profile for this ticker.

Performance

OTLK stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns OTLK?

Insider, institutional, and short-interest positioning.

Institutional ownership

+13.7%

Float: +85.3% of shares outstanding

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

OTLK momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

39.5

Neutral momentum band

Price vs 200-day MA

-79.3%

50/200-day relationship not available

Beta (5Y)

0.33

Less volatile than the market

Sharpe ratio

-0.53

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About OTLK

Hub-level FAQ points readers to the deeper analysis pages.

What is the current OTLK stock rating?

Outlook Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full OTLK analysis?

The full report lives at /stocks/OTLK/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for OTLK?

The latest report frames OTLK around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the OTLK page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.